Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
17.63
+1.57 (9.78%)
At close: Nov 6, 2026, 4:00 PM EST
17.85
+0.22 (1.24%)
After-hours: Nov 6, 2026, 5:49 PM EST
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.08 billion as of November 6, 2026. It is the 10,042nd most valuable company in the world and the 2,223rd biggest in the United States. Its market cap has decreased by 34.87% in one year.
Market Cap
1.08B
Enterprise Value
152.50M
1-Year Change
-34.87%
Global Rank
Country Rank
#2,223 United States
Category
ChartMarket Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.08B, an increase of 75.62%. That is a compound annual growth rate of 10.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.08B | 29.85% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 1.23B |
| Savara | 1.22B |
| Omeros | 1.22B |
| Vor Biopharma | 1.22B |
| UroGen Pharma | 1.21B |
| Silence Therapeutics | 1.19B |
| Seaport Therapeutics | 1.15B |
| Verastem | 1.02B |